MENU
+Compare
OCUL
Stock ticker: NASDAQ
AS OF
Jun 26, 04:37 PM (EDT)
Price
$9.43
Change
+$0.24 (+2.61%)
Capitalization
1.46B

OCUL Ocular Therapeutix Forecast, Technical & Fundamental Analysis

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye... Show more

OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for OCUL with price predictions
Jun 25, 2025

OCUL in upward trend: price rose above 50-day moving average on May 28, 2025

OCUL moved above its 50-day moving average on May 28, 2025 date and that indicates a change from a downward trend to an upward trend. In of 24 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where OCUL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 24, 2025. You may want to consider a long position or call options on OCUL as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OCUL just turned positive on June 25, 2025. Looking at past instances where OCUL's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for OCUL crossed bullishly above the 50-day moving average on May 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OCUL advanced for three days, in of 254 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 199 cases where OCUL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for OCUL moved out of overbought territory on June 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCUL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OCUL broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OCUL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.447) is normal, around the industry mean (16.539). P/E Ratio (0.000) is within average values for comparable stocks, (59.016). OCUL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (25.575) is also within normal values, averaging (255.605).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCUL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

OCUL is expected to report earnings to fall 6.42% to -35 cents per share on August 11

Ocular Therapeutix OCUL Stock Earnings Reports
Q2'25
Est.
$-0.36
Q1'25
Missed
by $0.09
Q4'24
Missed
by $0.04
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.04
The last earnings report on May 05 showed earnings per share of -37 cents, missing the estimate of -28 cents. With 991.67K shares outstanding, the current market capitalization sits at 1.46B.
A.I. Advisor
published General Information

General Information

a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPURX25.22N/A
N/A
Fidelity Puritan
SBHCX12.13N/A
N/A
Segall Bryant & Hamill Small Cap Cre Ret
ALVIX10.45N/A
N/A
American Century Focused Lg Cap Val Inv
LSVAX18.60N/A
N/A
Loomis Sayles Small Cap Value Admin
SMEYX16.18N/A
N/A
Invesco Small Cap Equity Y

OCUL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+1.10%
EYPT - OCUL
56%
Loosely correlated
+14.81%
DNLI - OCUL
55%
Loosely correlated
+0.35%
RNA - OCUL
51%
Loosely correlated
+0.10%
IMVT - OCUL
49%
Loosely correlated
-1.56%
RVMD - OCUL
49%
Loosely correlated
-4.05%
More